Free xml sitemap generator

Bibliography

HDR Bibliography

  1. Demanes D, Rodriguez R, Altieri G, High-dose brachytherapy: the California Endocurietherapy (CET) Method, Radiother Oncol, 2000;57:289–96.
  2. Stromberg J, Martinez A, Gonzalez J, et al., Ultrasound-guided high dose rate conformal brachytherapy boost in prostate cancer: Treatment description and preliminary results of a phase I/II clinical trial, Int J Radiat Oncol Biol Phys, 1995;33:161–71.
  3. Demanes D, Rodriguez R, Schour L, et al., High dose rate intensity-modulated brachytherapy with external beam radiotherapy for prostate cancer: California Endocurietherapy’s 10-year results, Int J Radiat Oncol Biol Phys, 2005;61:1306–16.
  4. Demanes D, Brandt D, Schour L, and Dennis R. Hill Excellent Results From High Dose Rate Brachytherapy and External Beam for Prostate Cancer are Not Impoved by Androgen Deprivation. American Journal of Clinical Oncology, 2009; 32(4):342-347.
  5. Schour L, Demanes, J, Altieri G, Dennis R. Hill et al., High Dose Rate Monotherapy for Prostate Cancer, Int J Radiat Oncol Biol Phys, 2005;(Suppl. 1):S315.
  6. Matched Pair analysis 117, ASTRO Annual Meeting, 2006.
  7. Eulau SM, Hollebeke L, Cavanagh W, et al., High dose rate Iridium 192 brachytherapy in localised prostate cancer: Results and toxicity with maximum follow-up of 10 years, Int J Radiat Oncol Biol Phys, 2000;48:149.
  8. Galalae R, Kovacs G, Schultze J, et al., Long-term outcome after elective irradiation of the pelvic lymphatics and local dose escalation using high dose rate brachytherapy for locally advanced prostate cancer, Int J Radiat Oncol Biol Phys, 2002;52:81–90.
  9. Pellizzon A, Nadalin W, Salvajoli J, Results of high dose rate afterloading brachytherapy boost to conventional external beam radiation therapy for initial and locally advanced prostate cancer, Radiother Oncol, 2003;66(2):167–72.
  10. Neumann T, Mark R, Akins S, Nair M, Interstitial High Dose Rate (HDR) Brachytherapy + IMRT versus HDR Monotherapy for Early Stage Prostate Cancer, Int J Radiat Oncol Biol Phys, 2005;63:S313.
  11. Phan T, Puthawala A, Sharma A, Syed A, Treatment of localised prostate cancer with external beam radiation therapy and high dose rate interstitial brachytherapy, Int J Radiat Oncol Biol Phys, 2005;63:S315.
  12. Yamada Y, Bhatia S, Zaider M, et al., Favourable clinical outcomes of three-dimensional computer-optimised high dose rate prostate brachytherapy in the management of localised prostate cancer, Brachytherapy, 2006;5(3):157–64.
  13. Martinez AA, Gustafson G, Gonzalez J, et al. Dose escalation using conformal high dose rate brachytherapy improves outcome in unfavourable prostate cancer, Int J Radiat Oncol Biol Phys, 2002;53:316–27.
  14. Borghede, G, Hedelin H, Holmang S, et al., Combined treatment with temporary short-term high dose rate Iridium-192 brachytherapy and external beam radiotherapy for irradiation of localised prostatic carcinoma, Radiother Oncol, 1997;44:237–44.
  15. Hsu I, Cabrera A, Weinberg V, et al., Combined modality treatment with high dose rate brachytherapy boost for locally advanced prostate cancer, Brachytherapy, 2005;4:202–6.
  16. Martinez A, Demanes DJ, Galalae R, et al., Lack of benefit from short course of androgen deprivation for unfavourable prostate cancer patients treated with an accelerated hypofractionated regime, Int J Radiat Oncol Biol Phys, 2005;62:1322–31.
  17. Vargas C, Galalae R, Demanes DJ, et al., Lack of benefit of pelvic radiation in prostate cancer patients with a high risk of positive pelvic lymph nodes treated with high-dose radiation, Int J Radiat Oncol Biol Phys, 2005;63:1474–82.
  18. Swanson T, et al., ASTRO Annual Meeting, 2007.
  19. Yoshioka Y, Nose T, Yoshida K, et al., High dose rate brachytherapy as monotherapy for localised prostate cancer: a retrospective analysis with special focus on tolerance and chronic toxicity, Int J Radiat Oncol Biol Phys, 2003;56:213–20.
  20. Mark R, Paul J, Anderson P, et al., Interstitial high dose rate (HDR) brachytherapy for early stage prostate cancer; A report of 193 cases, Brachytherapy, 20007;6:85–6.
  21. Demanes J, et al., ASTRO Annual Meeting, 2007.
  22. Duchesne GM, Peters LJ, What is the α/β ratio for prostate cancer? Rationale for hypofractionated high dose rate brachytherapy, Int J Radiat Oncol Biol Phys, 1999;44:747–8.
  23. Fowler J, Chappell R, Ritter M, Is α/β for prostate tumours really low?, Int J Radiat Oncol Biol Phys, 2001;50:1021–31.
  24. Orton C, High dose rate brachytherapy may be radiobiologically superior to low dose rate due to slow repair of late-responding normal tissue cells, Int J Radiat Oncol Biol Phys, 2001;49: 183–9.
  25. Brenner DJ, Martinez AA, Edmundson GK, et al., Direct evidence that prostate tumours show high sensitivity to fractionation (low α/β) ratio), similar to late-responding normal tissue, Int J Radiat Oncol Biol Phys, 2002;52:6–13.
  26. Brenner DJ, Hypofractionation for prostate cancer radiotherapy – What are the issues?, Int J Radiat Oncol Biol Phys, 2003;57: 912–14.
  27. Wang J, Li X, Yu C, DiBiase S, The low α/β ratio for prostate cancer: What does the clinical outcome of HDR brachytherapy tell us?, Int J Radiat Oncol Biol Phys, 2003;57:1101–8.
  28. Horwitz E, Levy LA, Martinez A, et al., The Post-treatment PSA Bounce for Prostate Cancer Patients Treated With External Beam RT or Permanent Brachytherapy Alone Is Not Biochemically or Clinically Significant: A Multi-Institutional Pooled Analysis of More Than 7,500 Patients, Int J Radiat Oncol Biol Phys, 2006;66(Suppl. 1):S205.
  29. D. Jeffrey Demanes, M.D, Dennis R. Hill, M.D. High Dose Rate Brachytherapy of Prostate Cancer. U.S. Oncological Disease, 2:98-102, December 2007.
  30. D. Jeffrey Demanes, Alvaro A. Martinez, Michel Ghilezan, Dennis R. Hill, Lionel Schour, Gary Gustafson. High Dose Rate Monotherapy: Safe and Effective Brachytherapy for Patients with Localized Prostate Cancer. International Journal of Radiation Oncology Biology Physics 81(5):1286-92 Dec 2011